|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.30 NOK | -1.47% |
|
+5.05% | -15.55% |
| 06-16 | DNB Carnegie Resumes Coverage of Photocure with Buy Rating and NOK82 Price Target | FW |
| 06-09 | Photocure, Artera Enter Research Partnership for Bladder Cancer Diagnostics | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 172M | |||||
| 1,001B | |||||
| 566B | |||||
| 393B | |||||
| 326B | |||||
| 276B |
- Stock Market
- Stocks
- PHO Stock
- Charts Photocure ASA
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
